CAR-T Oncology Sales Executive

Johnson & Johnson Co.; Columbia (SC); On-site; USD 120,000 - 190,000; Full time

Job summary

Johnson & Johnson is seeking an Executive Oncology Sales Specialist to support Columbia, SC territory. The role focuses on CAR-T therapies, developing relationships with CARYKTI Certified Treatment Centers, and driving appropriate utilization while delivering patient-centered service.

The OS will build knowledge of multiple myeloma therapies, call on community practices, and provide education to stakeholders, with accountability for sales results and compliant field activities.

Responsibilities

• Fulfill sales strategies by selling current and potential new oncology therapeutics.
• Demonstrate a working knowledge of the products' clinical efficacy, provide clinical support/information as needed, and achieve their sales quota.
• Conduct business analysis, actively prospect for new business within assigned territory, develop account strategies with District Manager to increase sales in the assigned territory.
• Develop customer specific pre- and post-call plans that include objectives, probes and supporting materials.
• Build customer dedication and identify and cultivate new relationships.
• Influence decision-makers by delivering a targeted sales message based on accurate clinical information, use approved sales and marketing materials, and execute marketing strategies at the local level.
• Use resources appropriately while working successfully with JJIM team members and counterparts to share ideas and information to enhance business results.
• Strong knowledge of assigned specialty products and their related markets in areas relevant to internal and external customers.
• Develop a complete understanding of the health care delivery system within each assigned account.

Job description

Johnson & Johnson is seeking an Executive Oncology Sales Specialist to support Columbia, SC territory. The role focuses on CAR-T therapies, developing relationships with CARYKTI Certified Treatment Centers, and driving appropriate utilization while delivering patient-centered service.

The OS will build knowledge of multiple myeloma therapies, call on community practices, and provide education to stakeholders, with accountability for sales results and compliant field activities.